Proceedings of the National Academy of Sciences · 2020 · 61 citations · 26 references
Life SciencesImmunologyPharmacologyCell SignalingInflammationSignal TransductionCirrhosisCytokine SignalingHepatic FibrosisInflammasome ActivationInflammatory SignalingLiver DiseaseAnimal Disease ModelsInflammasome Inhibition MechanismsInflammasome ModulationInflammasome RegulationInflammasome SignalingInflammatory CascadeMacrophage Inflammasome ActivationSoluble Guanylate Cyclase Stimulators
Significance Fatty liver, which is an initial step in the development of more severe complications such as liver cirrhosis, is prevalent worldwide in our society. This study demonstrates that stimulation of soluble guanylate cyclase (sGC), an enzyme producing the second messenger cGMP, protects against the most common features of fatty liver, namely inflammation and fibrosis, in animal models of the disease. Our study also provides an explanation for this protection and describes how sGC stimulation blocks the inflammasome (a protein complex responsible for the production of the potent proinflammatory cytokine interleukin-1β) in liver macrophages. The results of this study support the investigation of sGC stimulators, which are already approved for treatment in other conditions, in patients with fatty liver disease.
26
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text
Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal et al. · The Lancet · 2014 · 2.2K citations
Prakash Ramachandran, Antonella Pellicoro, Madeleine A. Vernon et al. · Proceedings of the National Academy of Sciences · 2012 · 985 citations · Full text
Life Sciences, Immunology, Pathology +17